famotidine has been researched along with Myocardial Infarction in 2 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Myocardial Infarction: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).
| Excerpt | Relevance | Reference |
|---|---|---|
| "It remains unclear whether concomitant use of omeprazole attenuates platelet function as compared with that of famotidine in patients with acute coronary syndromes (ACS) who receive clopidogrel." | 9.16 | Influence of omeprazole and famotidine on the antiplatelet effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes: a prospective, randomized, multicenter study. ( Endo, T; Fukui, K; Hibi, K; Himeno, H; Kimura, K; Morita, S; Sugano, T; Tsukahara, K; Umemura, S; Yano, H, 2012) |
| " However, the association of famotidine and acquired long QT syndrome has rarely been reported." | 7.72 | Famotidine and long QT syndrome. ( Hongo, RH; Kayser, SR; Lee, KW; Scheinman, MM; Tseng, ZH, 2004) |
| "It remains unclear whether concomitant use of omeprazole attenuates platelet function as compared with that of famotidine in patients with acute coronary syndromes (ACS) who receive clopidogrel." | 5.16 | Influence of omeprazole and famotidine on the antiplatelet effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes: a prospective, randomized, multicenter study. ( Endo, T; Fukui, K; Hibi, K; Himeno, H; Kimura, K; Morita, S; Sugano, T; Tsukahara, K; Umemura, S; Yano, H, 2012) |
| " However, the association of famotidine and acquired long QT syndrome has rarely been reported." | 3.72 | Famotidine and long QT syndrome. ( Hongo, RH; Kayser, SR; Lee, KW; Scheinman, MM; Tseng, ZH, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yano, H | 1 |
| Tsukahara, K | 1 |
| Morita, S | 1 |
| Endo, T | 1 |
| Sugano, T | 1 |
| Hibi, K | 1 |
| Himeno, H | 1 |
| Fukui, K | 1 |
| Umemura, S | 1 |
| Kimura, K | 1 |
| Lee, KW | 1 |
| Kayser, SR | 1 |
| Hongo, RH | 1 |
| Tseng, ZH | 1 |
| Scheinman, MM | 1 |
1 trial available for famotidine and Myocardial Infarction
| Article | Year |
|---|---|
Influence of omeprazole and famotidine on the antiplatelet effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes: a prospective, randomized, multicenter study.
Topics: Acute Coronary Syndrome; Aged; Anti-Ulcer Agents; Aspirin; Blood Platelets; Clopidogrel; Drug Antago | 2012 |
1 other study available for famotidine and Myocardial Infarction
| Article | Year |
|---|---|
Famotidine and long QT syndrome.
Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Electrocardiography; Famotidine; Heart Failure; Hi | 2004 |